DYNC1I1 and glioblastoma: Furthermore, we report a dramatic downregulation of DYNC1I1 in glioblastoma (GBM), which correlates with poorer patient survival, and demonstrate that lower DYNC1I1 expression in GBM cells coincides with more SK2 localized to the plasma membrane.